Published in FEBS Lett on April 06, 1987
SC35 autoregulates its expression by promoting splicing events that destabilize its mRNAs. EMBO J (2001) 3.55
Nucleotide sequence of the transforming gene of avian myeloblastosis virus. Science (1982) 3.12
Proviral rearrangements and overexpression of a new cellular gene (nov) in myeloblastosis-associated virus type 1-induced nephroblastomas. Mol Cell Biol (1992) 3.11
A potential splicing factor is encoded by the opposite strand of the trans-spliced c-myb exon. Proc Natl Acad Sci U S A (1992) 2.05
Proposal for a unified CCN nomenclature. Mol Pathol (2003) 1.98
Avian myeloblastosis virus transforming gene is related to unique chicken DNA regions separated by at least one intervening sequence. J Virol (1982) 1.97
novH: differential expression in developing kidney and Wilm's tumors. Am J Pathol (1998) 1.90
Acute leukemia viruses E26 and avian myeloblastosis virus have related transformation-specific RNA sequences but different genetic structures, gene products, and oncogenic properties. Proc Natl Acad Sci U S A (1982) 1.82
Growth control in simian virus 40-transformed rat cells: temperature-independent expression of the transformed phenotype in tsA transformants derived by agar selection. J Virol (1978) 1.81
Further study of beta-TGFs released by virally transformed and non-transformed cells. Int J Cancer (1985) 1.77
Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506. Cancer Res (2001) 1.42
Structural analysis of the human nov proto-oncogene and expression in Wilms tumor. Oncogene (1994) 1.40
Transcriptional down regulation of the nov proto-oncogene in fibroblasts transformed by p60v-src. Mol Cell Biol (1996) 1.39
Virus specified enzyme activity and RNA species in herpes simplex virus type 1 transformed mouse cells. J Gen Virol (1976) 1.38
Physical mapping of human loci homologous to the chicken nov proto-oncogene. Oncogene (1992) 1.26
Expression of the human NOV gene in first trimester fetal tissues. Anat Embryol (Berl) (2001) 1.23
Biologically active proviral clone of myeloblastosis-associated virus type 1: implications for the genesis of avian myeloblastosis virus. J Virol (1985) 1.23
A role for CCN3 (NOV) in calcium signalling. Mol Pathol (2002) 1.22
CCN proteins are distinct from, and should not be considered members of, the insulin-like growth factor-binding protein superfamily. J Clin Endocrinol Metab (2001) 1.21
Differential expression of the ccn3 (nov) proto-oncogene in human prostate cell lines and tissues. Mol Pathol (2001) 1.19
Antiproliferative activity of CCN3: involvement of the C-terminal module and post-translational regulation. J Cell Biochem (2007) 1.19
Downregulation of CCN3 expression as a potential mechanism for melanoma progression. Oncogene (2007) 1.19
The CCN family of genes: a brief history. Mol Pathol (2001) 1.18
Distinctive features of Drosophila alternative splicing factor RS domain: implication for specific phosphorylation, shuttling, and splicing activation. Mol Cell Biol (2001) 1.18
Inhibition of glioma cell growth and tumorigenic potential by CCN3 (NOV). Mol Pathol (2001) 1.15
Biosynthesis of Escherichia coli aspartate transcarbamylase. I. Parameters of gene expression and sequential biosynthesis of the subunits. J Mol Biol (1972) 1.14
The expression of ccn3 (nov) RNA and protein in the rat central nervous system is developmentally regulated. Mol Pathol (2001) 1.14
Chromosomal mapping and expression of the human cyr61 gene in tumour cells from the nervous system. Mol Pathol (1997) 1.13
Characterization of the expression of cellular retrovirus genes and oncogenes in feline cells. Hematol Oncol (1984) 1.12
Differential expression of novH and CTGF in human glioma cell lines. Clin Mol Pathol (1996) 1.11
Regulation of nov by WT1: a potential role for nov in nephrogenesis. Oncogene (1996) 1.10
Patterns of specific genomic alterations associated with poor prognosis in high-grade renal cell carcinomas. Cancer Genet Cytogenet (2001) 1.09
A developmental study of novH gene expression in human central nervous system. C R Acad Sci III (1998) 1.09
Characterization of multiple alternative RNAs resulting from antisense transcription of the PR264/SC35 splicing factor gene. Nucleic Acids Res (1997) 1.08
Several mRNAs with variable 3' untranslated regions and different stability encode the human PR264/SC35 splicing factor. Proc Natl Acad Sci U S A (1994) 1.02
Characterization of SRp46, a novel human SR splicing factor encoded by a PR264/SC35 retropseudogene. Mol Cell Biol (1998) 1.01
Organization of chicken DNA sequences homologous to the transforming gene of avian myeloblastosis virus. I. Restriction enzyme analysis of total DNA from normal and leukemic cells. J Virol (1982) 0.99
Report and abstracts on the first international workshop on the CCN family of genes. Mol Pathol (2001) 0.99
CCN proteins are distinct from and should not be considered members of the insulin-like growth factor-binding protein superfamily. Endocrinology (2000) 0.98
CCN3 is a novel endogenous PDGF-regulated inhibitor of glomerular cell proliferation. Kidney Int (2007) 0.97
Immunocytochemical localization of NOVH protein and ultrastructural characteristics of NCI-H295R cells. J Submicrosc Cytol Pathol (2001) 0.97
The PR264/c-myb connection: expression of a splicing factor modulated by a nuclear protooncogene. Proc Natl Acad Sci U S A (1992) 0.97
Host-virus interactions critical for cellular transformation by polyoma virus and SV40. Cold Spring Harb Symp Quant Biol (1980) 0.97
Induction of nephroblastoma by myeloblastosis-associated virus type 1: state of proviral DNAs in tumor cells. J Virol (1989) 0.95
C-myb proto-oncogene: evidence for intermolecular recombination of coding sequences. Oncogene (1991) 0.93
Cells transformed by Rous sarcoma virus release transforming growth factors. J Cell Physiol (1982) 0.93
Avian myeloblastosis virus: a model for the generation of viral oncogenes from potentially oncogenic cellular genetic elements. Folia Biol (Praha) (1983) 0.92
Genomic structure and chromosomal mapping of the mouse nov gene. Genomics (1996) 0.89
[Genetic alterations associated with pathologic differentiation of Wilms' tumors]. Bull Cancer (1997) 0.88
Pathogenic potential of myeloblastosis-associated virus: implication of env proteins for osteopetrosis induction. Virology (1993) 0.88
A novel type of RNA-binding protein is potentially encoded by the opposite strand of the trans-spliced c-myb coding exon. C R Acad Sci III (1991) 0.88
The expression of chicken NOV, a member of the CCN gene family, in early stage development. Brain Res Gene Expr Patterns (2001) 0.87
Transformation of Brown Leghorn chicken embryo fibroblasts by avian myeloblastosis virus proviral DNA. J Virol (1985) 0.87
Distinct transformation phenotypes induced by polyoma virus and simian virus 40 in rat fibroblasts and their control by an early viral gene function. J Virol (1980) 0.86
Expression of a gene encoding a novel potential IGF binding protein in human tissues. C R Acad Sci III (1991) 0.86
[Relationships between learning and memory and expression of nov gene of rats]. Sheng Li Xue Bao (2000) 0.85
Organization of 5'-proximal c-myb exons in chicken DNA. Implications for c-myb tissue-specific transcription. FEBS Lett (1988) 0.84
Intermolecular recombination of human c-myb proto-oncogene coding sequences. C R Acad Sci III (1991) 0.84
Two c-myb proteins differing by their aminotermini exhibit different transcriptional transactivation activities (yeast/reporter-effector system). Oncogene (1991) 0.83
The specificity of transcription in vitro of the tryptophan operon of Escherichia coli. II. The effect of Rho factor. Mol Gen Genet (1974) 0.83
Report and abstracts of the 3rd International Workshop on the CCN Family of Genes. St Malo, France, 20-23 October 2004. J Clin Pathol (2005) 0.82
Nucleotide sequence and organization of the transforming region and large terminal redundancies (LTR) of avian myeloblastosis virus (AMV). J Cell Biochem (1982) 0.80
[Cytology in the detection and followup of urothelial tumors. Critical review of 500 cytologic investigations (authors transl)]. J Urol (Paris) (1982) 0.79
Chromosomal reallocation of the chicken c-myb locus and organization of 3'-proximal coding exons. FEBS Lett (1990) 0.79
Biosynthesis of Escherichia coli aspartate transcarbamylase. II. Correlated biosynthesis of the catalytic and regulatory chains and cytoplasmic association of the subunits. J Mol Biol (1977) 0.78
Report on the fourth international workshop on the CCN family of genes. J Cell Commun Signal (2007) 0.78
Report on the fifth international workshop on the CCN family of genes. J Cell Commun Signal (2009) 0.78
Avian myeloblastosis provirus cloned in a lambda bacteriophage is leukemogenic. J Virol (1982) 0.78
Assignment of the chicken NOV gene (alias CCN3) to chromosome 2q34-->q36: Conserved and compared synteny between avian, mouse and human. Cytogenet Genome Res (2002) 0.78
A protein of Halobacterium halobium immunologically related to the v-myc gene product. FEBS Lett (1988) 0.78
Francisella tularensis meningitis. Med Mal Infect (2011) 0.78
Incorporation of amino acid analogs during the biosynthesis of Escherichia coli aspartate transcarbamylase. Biochim Biophys Acta (1980) 0.78
Values for the free to total prostate-specific antigen ratio as a function of age: necessity of reference range validation. Eur Urol (1999) 0.78
The noncoding and surface envelope coding sequences of myeloblastosis-associated virus are respectively responsible for nephroblastoma development and renal hyperplasia. J Virol (1996) 0.77
Retroviral insertional activation of the c-myb proto-oncogene in a Marek's disease T-lymphoma cell line. J Virol (1996) 0.77
Expression and synthesis of insulin-like growth factor (IGF)-I, -II and their receptors in human glioma cell lines. Int J Oncol (1996) 0.77
The carboxy-terminal domain of c-Myb activates reporter gene expression in yeast. Oncogene (1993) 0.76
HL-60 cells isolated for resistance to vincristine are defective in 12-O-tetradecanoylphorbol-13-acetate induced differentiation and the formation of a functional AP-1 complex. Oncol Res (1992) 0.76
v-myb transformation of Xeroderma pigmentosum human fibroblasts: overexpression of the c-Ha-ras oncogene in the transformed cells. Exp Cell Res (1991) 0.76
Cooperation between the H-ras oncogene and a truncated derivative of the v-myb oncogene in transformation of hamster embryo fibroblasts. Oncogene (1992) 0.76
Transforming potential of truncated v-myb and stimulation of replication by gag-myb fusion products. Oncogene (1992) 0.76
Alteration of C-MYB DNA binding to cognate responsive elements in HL-60 variant cells. Mol Pathol (2002) 0.75
myb-specific probes. Nucleic Acids Res (1987) 0.75